FindTrial
Sign In

Efficacy of high flow nasal oxygenation in non covid mild to moderate acute respiratory distress syndrome

Efficacy of high flow nasal oxygenation in non covid mild to moderate acute respiratory distress syndrome : A Prospective Observational Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094735
Enrollment
82
Registered
2025-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Priya Rathore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult 18-60years patient of either sex with ARDS with New Global Definition of ARDS 1 Acute onset within one week 2 Bilateral chest infiltrates in x ray or CT or Bilateral B lines and or consolidation in ultrasound 3 SpO2/FiO2 less than 315 4 PaO2/FiO2 less than 300 5 No evidence of left heart failure or fluid overload

Exclusion criteria

Exclusion criteria: 1 Severe ARDS PaO2/FiO2 less than 100 or SpO2/FiO2 less than 148 2 Covid positive patients. 3 Pregnant Female 4 Neurological condition, cardiac failure, structural heart disease 5 Any other co-existing lung pathology 6 Any contraindication for nasal canula (nasal obstruction, recent nasal surgery)

Design outcomes

Primary

MeasureTime frame
Requirement of Mechanical VentilationTimepoint: 24 hrs—

Secondary

MeasureTime frame
Discharge without mechanical ventilation eventTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr PRIYA RATHORE

King Georges Medical University

brij_kushwaha00634@yahoo.com9336900634

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026